Product Information
DOXEPIN 25 MG CAPSULE is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1280 per EA under NDC 00378312501. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
25 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378312501
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA070791On Market Since
5/13/1986
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN 25 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 30.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1280 per EA |
|---|---|
| All-time high | $0.6205 (Jan 11, 2017) |
| All-time low | $0.1216 (Nov 20, 2024) |
| 52-week high | $0.1404 |
| 52-week low | $0.1242 |
| Median price | $0.3355 |
| Average price | $0.3243 |
| Largest weekly change | +59.2% (Mar 20, 2019) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DOXEPIN 25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 25 MG CAPSULE, manufactured by Mylan Pharmaceuticals Inc., is $0.1280 per EA (NDC 00378312501), effective Jun 24, 2026.
How has the price of DOXEPIN 25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOXEPIN 25 MG CAPSULE has declined 30.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DOXEPIN 25 MG CAPSULE?
Since Nov 28, 2013, the NADAC for DOXEPIN 25 MG CAPSULE has ranged from a low of $0.1216 (Nov 20, 2024) to a high of $0.6205 (Jan 11, 2017), with a median of $0.3355 per EA.
Are there cheaper alternatives to DOXEPIN 25 MG CAPSULE?
4 NADAC-published products share the same active ingredient, strength, and dosage form as DOXEPIN 25 MG CAPSULE, but none are currently priced below it.
Who manufactures DOXEPIN 25 MG CAPSULE?
DOXEPIN 25 MG CAPSULE (NDC 00378312501) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification